https://orcid.org/0000-0002-7763-770X
Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ernesto Lopez, Sofía Hidalgo, Eduardo Roa, Javiera Gómez, Carlos Hermansen Truan, Evy Sanders, Cristian Carrasco, Rodrigo Pacheco, Flavio Salazar-Onfray, Manuel Varas-Godoy, Vincenzo Borgna & Alvaro Lladser. (2023) Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancer. OncoImmunology 12:1.
Read now
Read now
Raquel S Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, Daniel M Borras, Jannes Govaerts, Stefan Naulaerts, Zwi N Berneman, Benoit Beuselinck, Kalijn F Bol, Jannie Borst, an Coosemans, Angeliki Datsi, Jitka Fučíková, Lisa Kinget, Bart Neyns, Gerty Schreibelt, Evelien Smits, Rüdiger V Sorg, Radek Spisek, Kris Thielemans, Sandra Tuyaerts, Steven De Vleeschouwer, I Jolanda M de Vries, Yanling Xiao & Abhishek D Garg. (2022) Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. OncoImmunology 11:1.
Read now
Read now
Articles from other publishers (26)
Beatriz Amorós-Pérez, Benigno Rivas-Pardo, Manuel Gómez del Moral, José Luis Subiza & Eduardo Martínez-Naves. (2024) State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future?. Cells 13:9, pages 725.
Crossref
Crossref
Tingrui Zhang, Zongguang Tai, Fengze Miao, Xinyue Zhang, Jiadong Li, Quangang Zhu, Hua Wei & Zhongjian Chen. (2024) Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances. Journal of Controlled Release 368, pages 372-396.
Crossref
Crossref
Yunze Tai, Man Chen, Fang Wang, Yu Fan, Junlong Zhang, Bei Cai, Lin Yan, Yao Luo & Yi Li. (2024) The role of dendritic cells in cancer immunity and therapeutic strategies. International Immunopharmacology 128, pages 111548.
Crossref
Crossref
Rubén Arroyo-Olarte, Aranza Mejía-Muñoz & Sonia León-Cabrera. (2023) Expanded Alternatives of CRISPR–Cas9 Applications in Immunotherapy of Colorectal Cancer. Molecular Diagnosis & Therapy 28:1, pages 69-86.
Crossref
Crossref
Yu Cao, Sergey K. Efetov, Mingze He, Yu Fu, Narasimha M. Beeraka, Jin Zhang, Xinliang Zhang, Namitha Bannimath & Kuo Chen. (2023) Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer. Archivum Immunologiae et Therapiae Experimentalis 71:1.
Crossref
Crossref
Courtney Chen, Audrey Jung, Annie Yang, Isabel Monroy, Zhifang Zhang, Shyambabu Chaurasiya, Supriya Deshpande, Saul Priceman, Yuman Fong, Anthony K. Park & Yanghee Woo. (2023) Chimeric Antigen Receptor-T Cell and Oncolytic Viral Therapies for Gastric Cancer and Peritoneal Carcinomatosis of Gastric Origin: Path to Improving Combination Strategies. Cancers 15:23, pages 5661.
Crossref
Crossref
Vinayak Nayak, Sushmita Patra, Kshitij RB Singh, Bristy Ganguly, Das Nishant Kumar, Deepak Panda, Ganesh Kumar Maurya, Jay Singh, Sanatan Majhi, Rohit Sharma, Shyam S. Pandey, Ravindra Pratap Singh & Rout George Kerry. (2023) Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics. Environmental Research 235, pages 116573.
Crossref
Crossref
Tabassom Mohajershojai, Douglas Spangler, Saloni Chopra, Fredrik Y. Frejd, Paul J. Yazaki & Marika Nestor. (2023) Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts. Cancers 15:17, pages 4239.
Crossref
Crossref
Jian Chen, Tianchuan Zhu, Guanmin Jiang, Qi Zeng, Zhijian Li & Xi Huang. (2023) Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer. Molecular Cancer 22:1.
Crossref
Crossref
Chengcheng Zhang, Linling Wang, Qianzhen Zhang, Junjie Shen, Xia Huang, Meiling Wang, Yi Huang, Jun Chen, Yanmin Xu, Wenxu Zhao, Yanan Qi, Yunyan Li, Yanjiao Ou, Zhi Yang & Cheng Qian. (2023) Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma. Frontiers in Immunology 14.
Crossref
Crossref
Yun Wang, Yan Zhao, Miaoling Li, Huilian Hou, Zhijie Jian, Weizhi Li, Peijie Li, Fuquan Ma, Mengying Liu, Haibo Liu & Hui Xue. (2023) Conversion of primary liver cancer after targeted therapy for liver cancer combined with AFP-targeted CAR T-cell therapy: a case report. Frontiers in Immunology 14.
Crossref
Crossref
Arun Kumar Singh, Rishabha Malviya, Amrita Singh, Sonali Sundram & Sudhanshu Mishra. (2023) Chimeric Antigen Receptor (CAR) T-cell Therapy: A New Genetically Engineered
Method of Immunotherapy for Cancer. Current Cancer Drug Targets 23:3, pages 199-210.
Crossref
Crossref
Yuan Yuan, Fan Gao, Ying Chang, Qiu Zhao & Xingxing He. (2023) Advances of mRNA vaccine in tumor: a maze of opportunities and challenges. Biomarker Research 11:1.
Crossref
Crossref
Megan Minnix, Maciej Kujawski, Erasmus Poku, Paul J. Yazaki, Jeffrey Y. Wong & John E. Shively. (2022) Improved Tumor Responses with Sequential Targeted α-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice. Journal of Nuclear Medicine 63:12, pages 1859-1864.
Crossref
Crossref
Faroogh Marofi, Harun Achmad, Dmitry Bokov, Walid Kamal Abdelbasset, Zeid Alsadoon, Supat Chupradit, Wanich Suksatan, Siavash Shariatzadeh, Zahra Hasanpoor, Mahboubeh Yazdanifar, Navid Shomali & Farhad Motavalli Khiavi. (2022) Hurdles to breakthrough in CAR T cell therapy of solid tumors. Stem Cell Research & Therapy 13:1.
Crossref
Crossref
Timothy I. Shaw, Bi Zhao, Yuxin Li, Hong Wang, Liang Wang, Brandon Manley, Paul A. Stewart & Aleksandra Karolak. (2022) Multi-omics approach to identifying isoform variants as therapeutic targets in cancer patients. Frontiers in Oncology 12.
Crossref
Crossref
Azam Bozorgi, Maryam Bozorgi & Mozafar Khazaei. (2022) Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects. Cellular Oncology 45:5, pages 755-777.
Crossref
Crossref
Zhujiang Dai, Jihong Fu, Xiang Peng, Dong Tang & Jinglue Song. (2022) Intestinal Microbiota: The Driving Force behind Advances in Cancer Immunotherapy. Cancers 14:19, pages 4796.
Crossref
Crossref
Anjali Rao, Andrew Stewart, Mahmoud Eljalby, Praveen Ramakrishnan, Larry D. AndersonJr.Jr., Farrukh T. Awan, Alvin Chandra, Srilakshmi Vallabhaneni, Kathleen Zhang & Vlad G. Zaha. (2022) Cardiovascular disease and chimeric antigen receptor cellular therapy. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Lindsay Williams, Kenneth J. Dery, Wen-Hui Lee, Harry Li, John E. Shively & Maciej Kujawski. (2022) Isolation and expansion of murine γδ T cells from mouse splenocytes. Journal of Immunological Methods 508, pages 113322.
Crossref
Crossref
Long Chen, Fukun Chen, Huatao Niu, Jindan Li, Yongzhu Pu, Conghui Yang, Yue Wang, Rong Huang, Ke Li, Yujie Lei & Yunchao Huang. (2022) Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities. Frontiers in Immunology 13.
Crossref
Crossref
Parvin Akbari, Afroditi Katsarou, Roxanna Daghighian, Lotte W.H.G. van Mil, Elisabeth J.M. Huijbers, Arjan W. Griffioen & Judy R. van Beijnum. (2022) Directing CAR T cells towards the tumor vasculature for the treatment of solid tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:3, pages 188701.
Crossref
Crossref
Tabassom Mohajershojai, Preeti Jha, Anna Boström, Fredrik Y. Frejd, Paul J. Yazaki & Marika Nestor. (2022) In Vitro Characterization of 177Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer. Frontiers in Oncology 12.
Crossref
Crossref
Maciej Kujawski, Lin Li, Harry Li, Paul J. Yazaki, Piotr Swiderski & John E. Shively. (2021) T‐cell surface generation of dual bivalent, bispecific T‐cell engaging, RNA duplex cross‐linked antibodies (dbBiTERs) for re‐directed tumor cell lysis. Biotechnology Journal 17:2.
Crossref
Crossref
Aliyah B. Silver, Elissa K. Leonard, Joseph R. Gould & Jamie B. Spangler. (2021) Engineered antibody fusion proteins for targeted disease therapy. Trends in Pharmacological Sciences 42:12, pages 1064-1081.
Crossref
Crossref
Olga Zimmermannova, Inês Caiado, Alexandra G. Ferreira & Carlos-Filipe Pereira. (2021) Cell Fate Reprogramming in the Era of Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Crossref